Accueil・Liste d'Actions・Novartis AG

Novartis AG

Fermé

160.21 -0.02

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

159.01

Max

163.07

Chiffres clés
By Trading Economics
Revenu	-2.1B 1.2B
Ventes	611M 15B
P/E Moyenne du Secteur	31.239 68.089
BPA	2.46
Rendement du dividende	2.9
Marge bénéficiaire	7.958
Employés	75,267
EBITDA	-571M 5.4B

Recommandations
By TipRanks
Recommandations	Achat
Prévisions sur 12 Mois	-0.41% downside

Dividendes
By Acuity
Rendement du dividende Moyenne du Secteur	2.90% 1.98%

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	17B 309B
Ouverture précédente	160.23
Clôture précédente	160.21

Novartis AG Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

11 nov. 2026, 23:56 UTC

Belden Inc. is trading modestly lower in after-market hours following Wednesday's close, with the price currently around the middle of its one-month trading range.

11 nov. 2026, 23:56 UTC

DLocal Limited has been trading roughly flat in after-market hours, remaining effectively unchanged since Wednesday's close and positioned below its 20-day moving average.

11 nov. 2026, 23:56 UTC

Becton Dickinson and Co is trading modestly lower in after-market hours, having retraced from a brief uptick earlier in the session.

11 nov. 2026, 23:56 UTC

CareDx, Inc. is seeing a modest increase in after-market trading, gaining ground since Wednesday's close, and remains above its 20-day moving average.

11 nov. 2026, 23:56 UTC

APA Corporation shares are trading lower in after-market hours, continuing a decline since Wednesday's close and positioned below the 20-day moving average.

11 nov. 2026, 23:52 UTC

Macro News

The Dow Jones Index is declining amid a drop in global equities following Nvidia's after-hours decline and rising crude oil prices due to geopolitical tensions.

11 nov. 2026, 23:51 UTC

Correlated Moves

The U.S. dollar is modestly higher against the Thai baht amid expectations of tighter Federal Reserve monetary policy following recent inflation data.

11 nov. 2026, 23:51 UTC

Estee Lauder Companies Inc is seeing a modest increase in after-market trading, stabilizing above its 20-day moving average and near the upper end of its one-month range.

11 nov. 2026, 23:51 UTC

Capital One Financial Corp is trading higher in after-market hours, supported by significant gains in the Consumer Finance sub-sector.

11 nov. 2026, 23:51 UTC

Viasat Inc. is experiencing a significant decline in after-market trading, driven by geopolitical tensions and inflation concerns impacting investor sentiment.

11 nov. 2026, 23:51 UTC

City Holding Co declined nearly one percent in after-market trading, marking its third consecutive session of lower closes.

11 nov. 2026, 23:51 UTC

Ligand Pharmaceuticals is moving modestly lower after market close, influenced by geopolitical tensions and inflation data that exceeded forecasts, amid a broader market decline.

11 nov. 2026, 23:51 UTC

IRADIMED CORPORATION's shares are trading modestly lower in after-market hours, reflecting broader market declines amid geopolitical tensions and interest rate concerns.

11 nov. 2026, 23:51 UTC

S&T Bancorp Inc is trading lower in after-market hours, continuing a notable decline since Wednesday's close and reflecting unusual performance.

11 nov. 2026, 23:51 UTC

Walker & Dunlop Inc's shares rose in after-market trading, aligning with a broader increase in the Commercial & Residential Mortgage Finance sub-sector.

11 nov. 2026, 23:51 UTC

Medtronic PLC shares are lower in after-market trading, reflecting the broader market's decline amid geopolitical tensions and ongoing inflation concerns.

11 nov. 2026, 23:51 UTC

Realty Income Corporation's shares are modestly lower in after-market trading, reflecting broader market declines amid geopolitical tensions and inflation concerns.

11 nov. 2026, 23:51 UTC

Acushnet Holdings Corp is down nearly three-quarters of a percent in after-market trading, reflecting broader market declines amid ongoing geopolitical tensions and investor anxiety.

11 nov. 2026, 23:51 UTC

PENN Entertainment, Inc. is down in after-market trading, reaching its lowest point since Wednesday's close, marking three consecutive daily declines.

11 nov. 2026, 23:51 UTC

DraftKings Inc. is moving lower in after-market trading, reflecting a broader market decline amid ongoing geopolitical tensions and recent hot consumer price index readings.

11 nov. 2026, 23:51 UTC

Correlated Moves

Beam Therapeutics Inc. is trading lower in after-market hours, alongside the ARK Innovation ETF (ARKK), amid broader market declines and volatility.

11 nov. 2026, 23:51 UTC

UnitedHealth Group shares are trading lower in after-market hours, continuing a decline since Wednesday's close and remaining below its 20-day moving average.

11 nov. 2026, 23:51 UTC

UK Housing Market Faces Continued Weakness as RICS House Price Balance Forecasts -0.32% Amid Inflation Concerns

11 nov. 2026, 23:51 UTC

RBA Meeting Minutes on November 17, 2026, to address inflation concerns amid declining consumer and business confidence.

11 nov. 2026, 23:51 UTC

Core PPI for October 2026 set to release amid rising inflation concerns and potential Fed interest rate hikes following hotter-than-expected CPI data.

11 nov. 2026, 23:51 UTC

Japan's Machinery Orders Data Release on November 18 Expected Amid Mixed Economic Signals and Cautious Optimism for Business Investment.

11 nov. 2026, 23:51 UTC

Bank of America Corporation's shares are trading modestly higher in after-market hours, reflecting gains in the Diversified Banks sub-sector.

11 nov. 2026, 23:51 UTC

Kosmos Energy Ltd. is trading higher in after-market hours, having reached a notable peak shortly after the session began.

11 nov. 2026, 23:51 UTC

Hormel Foods Corp is advancing in after-market trading, gaining sharply since Wednesday's close and positioned well above its 20-day moving average.

11 nov. 2026, 23:51 UTC

News

A class action lawsuit has been filed against lululemon athletica Inc. for allegedly concealing declining demand and overstating its turnaround plan effectiveness.

Comparaison

Variation de prix

Novartis AG prévision

Objectif de Prix

By TipRanks

-0.41% baisse

Prévisions sur 12 Mois

Moyen 159.667 USD -0.41%

Haut 180 USD

Bas 136 USD

Basé sur 4 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

4 ratings

Achat

Maintien

Vente

Basé sur 4 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Novartis AG

Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. The company also provides Pluvicto, lutetium Lu 177 vipivotide tetraxetan, indicated for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer; and Lutathera, lutetium Lu 177 dotatate, a prescription medicine used to treat adults and children aged 12 years and older with gastroenteropancreatic neuroendocrine tumors. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. The company has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. It also has a research collaboration and license agreement with Schrödinger, Inc. to identify and develop various therapeutic candidates; and a strategic collaboration with Vyriad, Inc. for the discovery and development for vivo chimeric antigen receptor T-cell therapies. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.